Rossari Biotech said its subsidiaries, Unitop Chemicals Pvt Ltd and Tristar Intermediates Pvt Ltd, are re-evaluating their proposed capacity expansion plans in light of evolving business requirements and market conditions.

The company, in a regulatory filing under SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, stated that the previously announced expansion project, first disclosed on April 24, 2025, has been rescheduled.

As part of the revised approach, the implementation of the capacity addition will now be undertaken in a phased manner over the next two years, reflecting a more calibrated investment strategy aligned with current market dynamics.

"The overall strategic intent of the investment remains unchanged," informed the company's statement.